GRCh38/hg38 20p12.3(chr20:6336607-8577546)x1 |
copy number loss |
See cases [RCV000050903] |
Chr20:6336607..8577546 [GRCh38] Chr20:6317254..8558193 [GRCh37] Chr20:6265254..8506193 [NCBI36] Chr20:20p12.3 |
pathogenic |
GRCh38/hg38 20p12.3(chr20:7123110-8577546)x3 |
copy number gain |
See cases [RCV000050394] |
Chr20:7123110..8577546 [GRCh38] Chr20:7103757..8558193 [GRCh37] Chr20:7051757..8506193 [NCBI36] Chr20:20p12.3 |
pathogenic|uncertain significance|conflicting data from submitters |
GRCh38/hg38 20p12.3(chr20:7123110-8577546)x1 |
copy number loss |
Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000050395]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000050395]|See cases [RCV000050395] |
Chr20:7123110..8577546 [GRCh38] Chr20:7103757..8558193 [GRCh37] Chr20:20p12.3 |
pathogenic |
GRCh38/hg38 20p13-11.21(chr20:89939-25697564)x3 |
copy number gain |
See cases [RCV000051227] |
Chr20:89939..25697564 [GRCh38] Chr20:70580..25678200 [GRCh37] Chr20:18580..25626200 [NCBI36] Chr20:20p13-11.21 |
pathogenic |
GRCh38/hg38 20p13-11.23(chr20:89939-19146279)x3 |
copy number gain |
See cases [RCV000051041] |
Chr20:89939..19146279 [GRCh38] Chr20:70580..19126923 [GRCh37] Chr20:18580..19074923 [NCBI36] Chr20:20p13-11.23 |
pathogenic |
GRCh38/hg38 20p12.3-12.2(chr20:7566644-11028694)x1 |
copy number loss |
See cases [RCV000052739] |
Chr20:7566644..11028694 [GRCh38] Chr20:7547291..11009342 [GRCh37] Chr20:7495291..10957342 [NCBI36] Chr20:20p12.3-12.2 |
pathogenic |
GRCh38/hg38 20p13-11.23(chr20:89939-19071495)x3 |
copy number gain |
See cases [RCV000052995] |
Chr20:89939..19071495 [GRCh38] Chr20:70580..19052139 [GRCh37] Chr20:18580..19000139 [NCBI36] Chr20:20p13-11.23 |
pathogenic |
GRCh38/hg38 20p13-11.22(chr20:89939-21787252)x3 |
copy number gain |
Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052996]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052996]|See cases [RCV000052996] |
Chr20:89939..21787252 [GRCh38] Chr20:70580..21767890 [GRCh37] Chr20:18580..21715890 [NCBI36] Chr20:20p13-11.22 |
pathogenic |
GRCh38/hg38 20p13-12.1(chr20:89939-14818511)x3 |
copy number gain |
Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052997]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052997]|See cases [RCV000052997] |
Chr20:89939..14818511 [GRCh38] Chr20:70580..14799157 [GRCh37] Chr20:18580..14747157 [NCBI36] Chr20:20p13-12.1 |
pathogenic |
NM_017545.2(HAO1):c.722-5183G>T |
single nucleotide variant |
Lung cancer [RCV000101759] |
Chr20:7900407 [GRCh38] Chr20:7881054 [GRCh37] Chr20:20p12.3 |
uncertain significance |
GRCh38/hg38 20p12.3(chr20:7123110-8577546)x1 |
copy number loss |
See cases [RCV000050395] |
Chr20:7123110..8577546 [GRCh38] Chr20:7103757..8558193 [GRCh37] Chr20:7051757..8506193 [NCBI36] Chr20:20p12.3 |
pathogenic |
NM_017545.2(HAO1):c.*697T>C |
single nucleotide variant |
Nephrolithiasis, calcium oxalate [RCV000128597] |
Chr20:7882896 [GRCh38] Chr20:7863543 [GRCh37] Chr20:7811543 [NCBI36] Chr20:20p12.3 |
association |
NM_017545.3(HAO1):c.814-2945A>G |
single nucleotide variant |
Nephrolithiasis, calcium oxalate [RCV000128598] |
Chr20:7888809 [GRCh38] Chr20:7888809..7888810 [GRCh38] Chr20:7869456 [GRCh37] Chr20:7869456..7869457 [GRCh37] Chr20:7817456 [NCBI36] Chr20:20p12.3 |
association |
NM_017545.3(HAO1):c.814-4211G>A |
single nucleotide variant |
Nephrolithiasis, calcium oxalate [RCV000128599] |
Chr20:7890075 [GRCh38] Chr20:7870722 [GRCh37] Chr20:7818722 [NCBI36] Chr20:20p12.3 |
association |
NM_017545.3(HAO1):c.721+1617G>C |
single nucleotide variant |
Nephrolithiasis, calcium oxalate [RCV000128600] |
Chr20:7904537 [GRCh38] Chr20:7885184 [GRCh37] Chr20:7833184 [NCBI36] Chr20:20p12.3 |
association |
NM_017545.3(HAO1):c.545+1171T>C |
single nucleotide variant |
Nephrolithiasis, calcium oxalate [RCV000128601] |
Chr20:7912993 [GRCh38] Chr20:7893640 [GRCh37] Chr20:7841640 [NCBI36] Chr20:20p12.3 |
association |
NM_017545.3(HAO1):c.290-1983G>A |
single nucleotide variant |
Nephrolithiasis, calcium oxalate [RCV000128602] |
Chr20:7916402 [GRCh38] Chr20:7897049 [GRCh37] Chr20:7845049 [NCBI36] Chr20:20p12.3 |
association |
NM_017545.3(HAO1):c.290-4862A>G |
single nucleotide variant |
Nephrolithiasis, calcium oxalate [RCV000128603] |
Chr20:7919281 [GRCh38] Chr20:7899928 [GRCh37] Chr20:7847928 [NCBI36] Chr20:20p12.3 |
association |
NM_017545.3(HAO1):c.289+8188C>T |
single nucleotide variant |
Nephrolithiasis, calcium oxalate [RCV000128604] |
Chr20:7926296 [GRCh38] Chr20:7906943 [GRCh37] Chr20:7854943 [NCBI36] Chr20:20p12.3 |
association |
NM_017545.3(HAO1):c.289+5965C>T |
single nucleotide variant |
Nephrolithiasis, calcium oxalate [RCV000128605] |
Chr20:7928519 [GRCh38] Chr20:7909166 [GRCh37] Chr20:7857166 [NCBI36] Chr20:20p12.3 |
association |
NM_017545.3(HAO1):c.289+2189G>C |
single nucleotide variant |
Nephrolithiasis, calcium oxalate [RCV000128606] |
Chr20:7932295 [GRCh38] Chr20:7912942 [GRCh37] Chr20:7860942 [NCBI36] Chr20:20p12.3 |
association |
NM_017545.3(HAO1):c.137+329T>C |
single nucleotide variant |
Nephrolithiasis, calcium oxalate [RCV000128607] |
Chr20:7939957 [GRCh38] Chr20:7920604 [GRCh37] Chr20:7868604 [NCBI36] Chr20:20p12.3 |
association |
GRCh38/hg38 20p13-q11.1(chr20:80106-30227427)x3 |
copy number gain |
See cases [RCV000133996] |
Chr20:80106..30227427 [GRCh38] Chr20:60747..29462103 [GRCh37] Chr20:8747..28075764 [NCBI36] Chr20:20p13-q11.1 |
pathogenic |
GRCh38/hg38 20p12.3-12.1(chr20:6617695-13392559)x1 |
copy number loss |
See cases [RCV000135292] |
Chr20:6617695..13392559 [GRCh38] Chr20:6598342..13373206 [GRCh37] Chr20:6546342..13321206 [NCBI36] Chr20:20p12.3-12.1 |
pathogenic |
GRCh38/hg38 20p13-q13.33(chr20:99557-64277321)x3 |
copy number gain |
See cases [RCV000135859] |
Chr20:99557..64277321 [GRCh38] Chr20:80198..62908674 [GRCh37] Chr20:28198..62379118 [NCBI36] Chr20:20p13-q13.33 |
pathogenic |
GRCh38/hg38 20p12.3(chr20:6186076-8804328)x3 |
copy number gain |
See cases [RCV000138041] |
Chr20:6186076..8804328 [GRCh38] Chr20:6166723..8784975 [GRCh37] Chr20:6114723..8732975 [NCBI36] Chr20:20p12.3 |
uncertain significance |
GRCh38/hg38 20p13-12.1(chr20:80106-13029401)x3 |
copy number gain |
See cases [RCV000138677] |
Chr20:80106..13029401 [GRCh38] Chr20:60747..13010049 [GRCh37] Chr20:8747..12958049 [NCBI36] Chr20:20p13-12.1 |
pathogenic |
GRCh38/hg38 20p12.3(chr20:7336200-8078349)x3 |
copy number gain |
See cases [RCV000138624] |
Chr20:7336200..8078349 [GRCh38] Chr20:7316847..8058996 [GRCh37] Chr20:7264847..8006996 [NCBI36] Chr20:20p12.3 |
likely benign |
GRCh38/hg38 20p12.3(chr20:7137090-8095330)x3 |
copy number gain |
See cases [RCV000139794] |
Chr20:7137090..8095330 [GRCh38] Chr20:7117737..8075977 [GRCh37] Chr20:7065737..8023977 [NCBI36] Chr20:20p12.3 |
uncertain significance |
GRCh38/hg38 20p13-11.1(chr20:80927-26324843)x3 |
copy number gain |
See cases [RCV000142017] |
Chr20:80927..26324843 [GRCh38] Chr20:61568..26305479 [GRCh37] Chr20:9568..26253479 [NCBI36] Chr20:20p13-11.1 |
pathogenic |
GRCh38/hg38 20p12.3(chr20:7125410-8606171)x3 |
copy number gain |
See cases [RCV000142356] |
Chr20:7125410..8606171 [GRCh38] Chr20:7106057..8586818 [GRCh37] Chr20:7054057..8534818 [NCBI36] Chr20:20p12.3 |
uncertain significance |
GRCh38/hg38 20p13-12.3(chr20:1269303-8626911)x3 |
copy number gain |
See cases [RCV000142917] |
Chr20:1269303..8626911 [GRCh38] Chr20:1249947..8607558 [GRCh37] Chr20:1197947..8555558 [NCBI36] Chr20:20p13-12.3 |
pathogenic |
GRCh38/hg38 20p13-11.23(chr20:80928-18688031)x3 |
copy number gain |
See cases [RCV000143426] |
Chr20:80928..18688031 [GRCh38] Chr20:61569..18668675 [GRCh37] Chr20:9569..18616675 [NCBI36] Chr20:20p13-11.23 |
pathogenic |
GRCh38/hg38 20p12.3(chr20:7123110-8577546)x3 |
copy number gain |
See cases [RCV000148075] |
Chr20:7123110..8577546 [GRCh38] Chr20:7103757..8558193 [GRCh37] Chr20:7051757..8506193 [NCBI36] Chr20:20p12.3 |
uncertain significance |
NM_017545.3(HAO1):c.814-1G>C |
single nucleotide variant |
not provided [RCV000207501] |
Chr20:7885865 [GRCh38] Chr20:7866512 [GRCh37] Chr20:20p12.3 |
uncertain significance |
GRCh37/hg19 20p13-11.1(chr20:80198-26075841)x3 |
copy number gain |
See cases [RCV000239954] |
Chr20:80198..26075841 [GRCh37] Chr20:20p13-11.1 |
pathogenic |
GRCh37/hg19 20p13-12.1(chr20:4392930-12667768)x1 |
copy number loss |
See cases [RCV000446718] |
Chr20:4392930..12667768 [GRCh37] Chr20:20p13-12.1 |
pathogenic |
GRCh37/hg19 20p12.3-12.1(chr20:7352576-12248958)x3 |
copy number gain |
See cases [RCV000448374] |
Chr20:7352576..12248958 [GRCh37] Chr20:20p12.3-12.1 |
uncertain significance |
GRCh37/hg19 20p12.3(chr20:7103757-8075977)x3 |
copy number gain |
not specified [RCV000487459] |
Chr20:7103757..8075977 [GRCh37] Chr20:20p12.3 |
uncertain significance |
GRCh37/hg19 20p13-q11.21(chr20:80198-26208081)x3 |
copy number gain |
not provided [RCV000487461] |
Chr20:80198..26208081 [GRCh37] Chr20:20p13-q11.21 |
pathogenic |
GRCh37/hg19 20p12.3(chr20:7103757-8558193)x3 |
copy number gain |
not provided [RCV000509139] |
Chr20:7103757..8558193 [GRCh37] Chr20:20p12.3 |
not provided |
GRCh37/hg19 20p12.3(chr20:6143179-8611534)x1 |
copy number loss |
See cases [RCV000511512] |
Chr20:6143179..8611534 [GRCh37] Chr20:20p12.3 |
likely pathogenic |
GRCh37/hg19 20p13-12.3(chr20:2463101-8185680)x1 |
copy number loss |
See cases [RCV000511897] |
Chr20:2463101..8185680 [GRCh37] Chr20:20p13-12.3 |
pathogenic |
GRCh37/hg19 20p12.3(chr20:7106057-8586513)x3 |
copy number gain |
See cases [RCV000511116] |
Chr20:7106057..8586513 [GRCh37] Chr20:20p12.3 |
likely benign |
GRCh37/hg19 20p13-q13.33(chr20:61569-62915555)x3 |
copy number gain |
See cases [RCV000510832] |
Chr20:61569..62915555 [GRCh37] Chr20:20p13-q13.33 |
pathogenic |
GRCh37/hg19 20p13-q13.33(chr20:61569-62915555) |
copy number gain |
See cases [RCV000512450] |
Chr20:61569..62915555 [GRCh37] Chr20:20p13-q13.33 |
pathogenic |
GRCh37/hg19 20p13-12.2(chr20:61568-10486106)x3 |
copy number gain |
See cases [RCV000512556] |
Chr20:61568..10486106 [GRCh37] Chr20:20p13-12.2 |
likely pathogenic |
GRCh37/hg19 20p12.3(chr20:7092359-8586513)x3 |
copy number gain |
not provided [RCV000684130] |
Chr20:7092359..8586513 [GRCh37] Chr20:20p12.3 |
uncertain significance |
GRCh37/hg19 20p12.3-12.1(chr20:7604120-14739025)x3 |
copy number gain |
not provided [RCV000684133] |
Chr20:7604120..14739025 [GRCh37] Chr20:20p12.3-12.1 |
pathogenic |
GRCh37/hg19 20p12.3(chr20:7716643-9158286)x1 |
copy number loss |
not provided [RCV000684129] |
Chr20:7716643..9158286 [GRCh37] Chr20:20p12.3 |
uncertain significance |
GRCh37/hg19 20p13-12.1(chr20:3092739-17091453)x1 |
copy number loss |
not provided [RCV000684134] |
Chr20:3092739..17091453 [GRCh37] Chr20:20p13-12.1 |
pathogenic |
GRCh37/hg19 20p13-q13.33(chr20:63244-62948788)x3 |
copy number gain |
not provided [RCV000741058] |
Chr20:63244..62948788 [GRCh37] Chr20:20p13-q13.33 |
pathogenic |
GRCh37/hg19 20p13-q13.33(chr20:63244-62961294)x3 |
copy number gain |
not provided [RCV000741059] |
Chr20:63244..62961294 [GRCh37] Chr20:20p13-q13.33 |
pathogenic |
GRCh37/hg19 20p13-q13.33(chr20:63244-62912463)x3 |
copy number gain |
not provided [RCV000741057] |
Chr20:63244..62912463 [GRCh37] Chr20:20p13-q13.33 |
pathogenic |
GRCh37/hg19 20p12.3(chr20:7106057-8085390)x3 |
copy number gain |
Autism [RCV002285118] |
Chr20:7106057..8085390 [GRCh37] Chr20:20p12.3 |
uncertain significance |
GRCh37/hg19 20p12.3(chr20:7092284-8586513)x3 |
copy number gain |
not provided [RCV000849753] |
Chr20:7092284..8586513 [GRCh37] Chr20:20p12.3 |
uncertain significance |
GRCh37/hg19 20p12.3(chr20:7106057-8572824)x3 |
copy number gain |
not provided [RCV000848179] |
Chr20:7106057..8572824 [GRCh37] Chr20:20p12.3 |
uncertain significance |
GRCh37/hg19 20p12.3(chr20:7106288-8572965)x1 |
copy number loss |
not provided [RCV000847804] |
Chr20:7106288..8572965 [GRCh37] Chr20:20p12.3 |
uncertain significance |
GRCh37/hg19 20p12.3(chr20:7548348-8317079)x3 |
copy number gain |
not provided [RCV000848267] |
Chr20:7548348..8317079 [GRCh37] Chr20:20p12.3 |
uncertain significance |
GRCh37/hg19 20p12.3(chr20:7374347-8111284)x3 |
copy number gain |
not provided [RCV001007078] |
Chr20:7374347..8111284 [GRCh37] Chr20:20p12.3 |
likely benign |
GRCh37/hg19 20p13-11.1(chr20:61568-26305479)x3 |
copy number gain |
not provided [RCV001007068] |
Chr20:61568..26305479 [GRCh37] Chr20:20p13-11.1 |
pathogenic |
GRCh37/hg19 20p12.3(chr20:7052456-8140338)x3 |
copy number gain |
not provided [RCV001007077] |
Chr20:7052456..8140338 [GRCh37] Chr20:20p12.3 |
uncertain significance |
NC_000020.10:g.(?_7812350)_(10654278_?)dup |
duplication |
Alagille syndrome due to a JAG1 point mutation [RCV003120764] |
Chr20:7812350..10654278 [GRCh37] Chr20:20p12.3-12.2 |
likely benign|uncertain significance |
GRCh37/hg19 20p12.3-12.1(chr20:7352576-12248958) |
copy number gain |
not specified [RCV002052698] |
Chr20:7352576..12248958 [GRCh37] Chr20:20p12.3-12.1 |
uncertain significance |
GRCh37/hg19 20p12.3(chr20:7036007-8138271)x3 |
copy number gain |
not provided [RCV001834419] |
Chr20:7036007..8138271 [GRCh37] Chr20:20p12.3 |
uncertain significance |
NM_017545.3(HAO1):c.1099G>A (p.Val367Ile) |
single nucleotide variant |
not specified [RCV004301818] |
Chr20:7883607 [GRCh38] Chr20:7864254 [GRCh37] Chr20:20p12.3 |
uncertain significance |
NM_017545.3(HAO1):c.392T>C (p.Leu131Pro) |
single nucleotide variant |
not specified [RCV004313945] |
Chr20:7914317 [GRCh38] Chr20:7894964 [GRCh37] Chr20:20p12.3 |
uncertain significance |
GRCh37/hg19 20p13-12.2(chr20:3178539-11848383) |
copy number loss |
20p12.3 microdeletion syndrome [RCV002280726] |
Chr20:3178539..11848383 [GRCh37] Chr20:20p13-12.2 |
pathogenic |
GRCh37/hg19 20p12.3(chr20:7548252-8315350)x4 |
copy number gain |
not provided [RCV002472877] |
Chr20:7548252..8315350 [GRCh37] Chr20:20p12.3 |
uncertain significance |
GRCh37/hg19 20p12.3(chr20:7106058-8586513)x3 |
copy number gain |
not provided [RCV002473845] |
Chr20:7106058..8586513 [GRCh37] Chr20:20p12.3 |
uncertain significance |
NM_017545.3(HAO1):c.97G>A (p.Asp33Asn) |
single nucleotide variant |
not specified [RCV004109733] |
Chr20:7940326 [GRCh38] Chr20:7920973 [GRCh37] Chr20:20p12.3 |
uncertain significance |
NM_017545.3(HAO1):c.826C>T (p.Pro276Ser) |
single nucleotide variant |
not specified [RCV004144627] |
Chr20:7885852 [GRCh38] Chr20:7866499 [GRCh37] Chr20:20p12.3 |
uncertain significance |
NM_017545.3(HAO1):c.188C>T (p.Ser63Leu) |
single nucleotide variant |
Inborn genetic diseases [RCV002732635] |
Chr20:7934585 [GRCh38] Chr20:7915232 [GRCh37] Chr20:20p12.3 |
uncertain significance |
NM_017545.3(HAO1):c.553A>T (p.Asn185Tyr) |
single nucleotide variant |
not specified [RCV004083945] |
Chr20:7906322 [GRCh38] Chr20:7886969 [GRCh37] Chr20:20p12.3 |
uncertain significance |
NM_017545.3(HAO1):c.515G>A (p.Arg172His) |
single nucleotide variant |
not specified [RCV004091864] |
Chr20:7914194 [GRCh38] Chr20:7894841 [GRCh37] Chr20:20p12.3 |
uncertain significance |
NM_017545.3(HAO1):c.295C>G (p.Gln99Glu) |
single nucleotide variant |
not specified [RCV004158746] |
Chr20:7914414 [GRCh38] Chr20:7895061 [GRCh37] Chr20:20p12.3 |
uncertain significance |
NM_017545.3(HAO1):c.631A>G (p.Lys211Glu) |
single nucleotide variant |
not specified [RCV004098331] |
Chr20:7906244 [GRCh38] Chr20:7886891 [GRCh37] Chr20:20p12.3 |
uncertain significance |
NM_017545.3(HAO1):c.817G>A (p.Asp273Asn) |
single nucleotide variant |
not specified [RCV004215568] |
Chr20:7885861 [GRCh38] Chr20:7866508 [GRCh37] Chr20:20p12.3 |
uncertain significance |
NM_017545.3(HAO1):c.773C>T (p.Ser258Leu) |
single nucleotide variant |
not specified [RCV004077117] |
Chr20:7895173 [GRCh38] Chr20:7875820 [GRCh37] Chr20:20p12.3 |
uncertain significance |
NM_017545.3(HAO1):c.883C>T (p.Arg295Trp) |
single nucleotide variant |
not specified [RCV004187872] |
Chr20:7885795 [GRCh38] Chr20:7866442 [GRCh37] Chr20:20p12.3 |
uncertain significance |
NM_017545.3(HAO1):c.952G>A (p.Val318Ile) |
single nucleotide variant |
not specified [RCV004080099] |
Chr20:7885726 [GRCh38] Chr20:7866373 [GRCh37] Chr20:20p12.3 |
likely benign |
NM_017545.3(HAO1):c.478G>C (p.Asp160His) |
single nucleotide variant |
not specified [RCV004140313] |
Chr20:7914231 [GRCh38] Chr20:7894878 [GRCh37] Chr20:20p12.3 |
uncertain significance |
GRCh38/hg38 20p13-11.21(chr20:87153-23635465)x3 |
copy number gain |
Renal agenesis [RCV003327640] |
Chr20:87153..23635465 [GRCh38] Chr20:20p13-11.21 |
pathogenic |
GRCh37/hg19 20p12.3(chr20:7106058-8573589)x1 |
copy number loss |
not provided [RCV003483357] |
Chr20:7106058..8573589 [GRCh37] Chr20:20p12.3 |
uncertain significance |
GRCh37/hg19 20p13-12.2(chr20:61569-9542361)x3 |
copy number gain |
not provided [RCV003485207] |
Chr20:61569..9542361 [GRCh37] Chr20:20p13-12.2 |
pathogenic |
NM_017545.3(HAO1):c.493G>T (p.Gly165Cys) |
single nucleotide variant |
glycolate oxidase deficiency [RCV003459941] |
|
pathogenic |
GRCh37/hg19 20p12.3-12.2(chr20:7856703-11991178)x1 |
copy number loss |
not specified [RCV003986129] |
Chr20:7856703..11991178 [GRCh37] Chr20:20p12.3-12.2 |
pathogenic |
GRCh37/hg19 20p13-12.1(chr20:68351-16142323)x3 |
copy number gain |
not provided [RCV003885494] |
Chr20:68351..16142323 [GRCh37] Chr20:20p13-12.1 |
pathogenic |
GRCh37/hg19 20p13-11.21(chr20:68351-23860313)x3 |
copy number gain |
not provided [RCV003885495] |
Chr20:68351..23860313 [GRCh37] Chr20:20p13-11.21 |
pathogenic |
NM_017545.3(HAO1):c.788G>A (p.Arg263Gln) |
single nucleotide variant |
not specified [RCV004399058] |
Chr20:7895158 [GRCh38] Chr20:7875805 [GRCh37] Chr20:20p12.3 |
uncertain significance |
NM_017545.3(HAO1):c.410G>A (p.Arg137Gln) |
single nucleotide variant |
not specified [RCV004399056] |
Chr20:7914299 [GRCh38] Chr20:7894946 [GRCh37] Chr20:20p12.3 |
uncertain significance |
NM_017545.3(HAO1):c.379C>T (p.Arg127Cys) |
single nucleotide variant |
not specified [RCV004399055] |
Chr20:7914330 [GRCh38] Chr20:7894977 [GRCh37] Chr20:20p12.3 |
uncertain significance |
NM_017545.3(HAO1):c.267C>A (p.Asp89Glu) |
single nucleotide variant |
not specified [RCV004399054] |
Chr20:7934506 [GRCh38] Chr20:7915153 [GRCh37] Chr20:20p12.3 |
uncertain significance |
NM_017545.3(HAO1):c.499C>T (p.Arg167Cys) |
single nucleotide variant |
not specified [RCV004399057] |
Chr20:7914210 [GRCh38] Chr20:7894857 [GRCh37] Chr20:20p12.3 |
uncertain significance |
NC_000020.10:g.(?_7812350)_(10654278_?)del |
deletion |
Alagille syndrome due to a JAG1 point mutation [RCV004579455]|Developmental and epileptic encephalopathy, 12 [RCV004579456] |
Chr20:7812350..10654278 [GRCh37] Chr20:20p12.3-12.2 |
pathogenic |